Oura Files IPO as Rivals Storm Its Smart Ring Kingdom

Oura’s IPO filing on September 3 and its $1.21 billion in revenue for nine months looks like a victory lap. It’s not. It’s a tactical retreat into Wall Street’s arms just as a pack of rivals storm its castle from five different directions according to TechCrunch. The smart ring market, once a sleepy niche, is now a frenzied battleground where competitors are no longer just copying Oura’s homework, they’re trying to outsmart it with payments, haptics, and on-device AI. This isn't a coronation. It's a cage fight for your finger.

The IPO Buzz Is Just a Distraction from Oura's Real Fight

The $1.21 billion revenue figure and 3.6 million rings sold are impressive. They're also a smokescreen. They represent past dominance in a market that has fundamentally changed in the last 12 months. While Oura prepares its S-1, its competitors are launching products designed to exploit its weaknesses: its closed ecosystem, its morning-after data summaries, and the lingering shadow of its subscription model.

The war is no longer about who has the best sleep tracking. It's about which company can turn a passive health monitor into an active, intuitive, and connected device. French company Circular is adding NFC for tap-to-pay. Chinese firm RingConn built in haptic vibrations for real-time alerts. India's Ultrahuman, fresh from a $70 million funding round, wants to run software and AI directly on the ring. As we reported in 'Coin Flip' Sleep Data Exposed as Oura Ring Sparks Lawsuit, data trust is a critical vulnerability. These challengers aren't just competing on metrics. They're competing on a philosophy of immediacy and actionability that Oura's once-innovative model now struggles to match.

From Stealth Launch to Mainstream Frenzy: How Oura Lost Its Invincibility

Oura's early playbook was masterful. It created a luxury health accessory, leveraged celebrity endorsements, and pioneered a software-as-a-service model for a piece of jewelry. For years, it had no real competitor. That changed when the market proved there was real money to be made.

The turning point was Oura's own success. Its subscription model, while lucrative, created a clear opening for rivals. It invited a simple question from consumers and entrepreneurs alike: "What if I didn't have to pay a monthly fee for my own data?" More critically, Oura's focus on being a premium, summary-focused device left the door wide open for features that provide value in the moment. Why wait for a morning report if your ring can vibrate to warn of a potential AFib episode, as Circular's upcoming Ring 3 Pro promises with its FDA-cleared ECG? Why have a silent health tracker when it could nudge you to stand up or alert you to a stress spike, as RingConn does?

"The race to beat Oura isn’t just about enhanced health and sleep tracking anymore. It’s now about seeing which company can cram the most smartphone-like features into a two-gram titanium band."

Oura's response, the slimmer Ring 5, feels iterative. Meanwhile, competitors are making revolutionary claims. Ultrahuman had to completely redesign its ring to circumvent a patent loss to Oura in the U.S. That forced innovation birthed the Ring Pro, which it claims has superior heart-rate sensing and on-device processing. Being forced to innovate to survive made Ultrahuman more dangerous, not less.

The Ring Wars by the Numbers: Subscriptions, Sensors, and Market Share

The raw numbers from Oura tell a story of scale, but the specs from its rivals tell a story of ambition.

Oura's Dominance (For Now)

• Revenue: $1.21 billion for the nine months ended June 30, 2026.
• Rings Sold: 3.6 million over the past year.
• Paid Members: Approximately 5 million.
• Key Hardware: Details of the Ring 5 are scant, positioned as the "slimmest and lightest yet."

The Contenders' Specs

The data shows a clear split. Oura competes on brand and scale. Ultrahuman and Circular compete on advanced, medical-adjacent sensing and proactive features. RingConn and Samsung compete on price and integration. Dreame competes on novel control schemes. The market is segmenting before it has even fully matured, suggesting a brutal fight for the mainstream middle ground.

Competitor Playbooks: How Each Challenger Plans to Win Your Finger

Each rival has a distinct theory on how to beat Oura, and none of them involve doing the same thing better.

Ultrahuman and Circular: The Medical-Grade Offensive These companies are bypassing the wellness tracker label and aiming for clinical relevance. Ultrahuman's post-patent redesign focuses on "improving signal quality during sleep," a direct attack on the core of Oura's value proposition. Its fundraising for on-device AI suggests a future where the ring doesn't just collect data, but interprets and acts on it independently. Circular's play is even more direct: FDA clearance for AFib detection and promises of glucose tracking position its ring not as an accessory, but as a potential lifesaver. This follows a broader trend in fintech where 65% of Payments Firms Automating Identity Now (/fintech/identity-automation-payments-firms-survey), signaling a shift toward proactive, automated systems.

Samsung and the Ecosystem Gambit Samsung took a different path. Its Galaxy Ring is "relatively basic" in health features, lacking sleep apnea or AFib detection. Its bet is that seamless integration with the Galaxy phone, watch, and tablet ecosystem is more valuable than best-in-class metrics. For a certain user, it is. This is a walled-garden play, mirroring strategies in other tech sectors.

RingConn and Dreame: The Interaction Experiment RingConn uses vibration as a "health-alert mechanism." Dreame adds a touchpad. These are attempts to solve a different problem: making the ring useful in the moment without grabbing your phone. It's a rejection of the "wear it and forget it" philosophy, embracing mild intrusion for greater utility.

For Wearers and Investors, This Means More Than Just a Choice of Jewelry

For consumers, the sudden competition is an unalloyed good. Feature wars drive innovation and can pressure prices. The subscription model is no longer a given. Data ownership and real-time insights are becoming standard demands. The user is in control.

For investors, especially those looking at Oura's IPO, the calculus is tricky. Backing Oura is a bet that its brand loyalty and first-mover advantage can withstand a multi-front war of innovation. Backing a challenger is a bet on a specific niche: Ultrahuman for AI-powered health, Circular for medical monitoring, Samsung for ecosystem lock-in. There may not be one "winner" in the traditional sense, but several profitable specialists. This is a shift from betting on a company to betting on an approach, similar to the strategic pivot banks are making as they Dump Billions in FinTech Deposits in BaaS Pivot (/fintech/banks-baas-strategy-fees-deposits-pivot).

The biggest casualty might be the basic smartwatch. As rings gain features like payments, notifications, and advanced health monitoring, they encroach directly on the smartwatch's territory while offering a form factor many find less intrusive.

The Future Fingerprint: Predictions for the Next Generation of Smart Rings

Two things are now certain. First, consolidation is coming. The market cannot support six companies all spending heavily on R&D for a device that, ultimately, lives in a very small real estate. Not every player in today's list will have a next-generation ring.

Second, the winning formula will not simply be "more sensors." It will be a masterful blend of three elements:

1. Medically-credible data that users and potentially their doctors can trust.
2. Intuitive, minimally intrusive interaction that provides value without becoming a distraction.
3. Seamless integration into a broader system, whether that's a phone ecosystem, a healthcare platform, or a payment network.

The final irony, as TechCrunch notes, is stark. Smart rings were supposed to be the antidote to screen-filled, intrusive wearables. But the race to beat Oura is rapidly turning them into "mini smartphones on our fingers." The company that wins won't be the one that crams in the most features. It will be the one that remembers the original promise, technology that helps you live better, not live through it, and delivers on it without adding digital friction back into your life. Watch which companies start paring back features in their next releases. That will be the sign of a mature market and a confident leader.

The Bottom Line

• Consumers will have more choice and advanced features as competitors innovate beyond basic health tracking.
• The shift from passive data summaries to active, real-time alerts could redefine how people use wearable tech daily.
• Oura's move to go public is a defensive play in a rapidly changing market, signaling intense competition ahead.